updated 9/9/2010 5:21:02 PM ET 2010-09-09T21:21:02

FAIRFIELD, Conn., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQB:CTTC) announced that Spero Pain Relief Therapy, based in St. George, UT, is the first clinic in Utah treating patients with CTTC's Calmare® Pain Therapy Treatment medical device. Patients suffering from various types of pain are being treated successfully under the direction of Robert Chalmers, M.D.

"We are excited to have Dr. Chalmers and Spero Pain Relief Therapy, with plans for three more pain treatment clinics in Utah, utilizing our Calmare Pain Therapy Treatment device," said Johnnie Johnson, CTTC's interim CEO. "We are all committed to improving patients' quality of life. We are convinced that, in addition to successfully treating patients suffering from chemotherapy-induced peripheral neuropathy (CIPN), our Calmare device successfully treats chronic neuropathic pain resulting from cancer, cancer chemotherapy, phantom limb syndrome, failed back surgery, sciatica, spinal stenosis, shingles and other maladies. And it does so non-invasively, without the use of harmful narcotic pain relievers." 

About Spero Pain Relief Therapy

Spero Pain Relief Therapy was founded by Dr. Robert Chalmers to provide innovative solutions to patients suffering from chronic pain. Visit Spero Pain Relief Therapy's website: www.sperotherapy.com .

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTTC is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTTC maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTTC's website: www.competitivetech.net .

The non-invasive Calmare® pain therapy device uses the biophysical "Scrambler Therapy" technology, which was developed in Italy by CTTC's client, Professor Giuseppe Marineo. CTTC's partner, GEOMC Co. Ltd. of Seoul, Korea is manufacturing the Calmare device, which has U.S. FDA clearance and European Union CE Mark clearance for sales. For more information about Calmare Pain Therapy Treatment, visit www.CalmareTT.com .

Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2009, filed with the SEC on October 27, 2009, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.71%
$30K home equity loan FICO 5.26%
$75K home equity loan FICO 4.70%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.42%
13.42%
Cash Back Cards 17.94%
17.94%
Rewards Cards 17.14%
17.14%
Source: Bankrate.com